Each peptide is synthesised, filled, lyophilised and QA-released under the same national drug manufacturing license, and ships with a certificate of analysis.
Two compounds in a single 3 mL cartridge, one administration. Current SKUs include BPC-157 with TB-500, CJC-1295 with Ipamorelin, and PT-141 with Oxytocin.
Compounding eligibility varies by substance and is confirmed against current FDA bulk drug substance lists at the point of order. Listing here is not a representation that any substance is eligible for any particular use.
The figure on the certificate is the figure measured on that lot — purity, assay, endotoxin and sterility — never averaged from a batch. If the record does not match the cartridge, we do not take the lot.
Every lot released to a physician account carries its certificate. The archives are public; the manufacturer identity behind them is released on NDA.
Verified physician accounts receive the full portfolio sheet, current SKU availability and per-compound eligibility on request.
